UK and US to smooth capital markets access and crypto cooperation
UK and US to smooth capital markets access and crypto cooperation
Source link
Similar Posts
Aimfinity Investment Corp. I Adjourned Shareholder Meeting and Revised Contribution to Trust Account in Connection with the Proposed Charter Amendment
Wilmington, DE, Dec. 31, 2024 (GLOBE NEWSWIRE) — Aimfinity Investment Corp. I (the “Company” or “AIMA”) (Nasdaq: AIMAU), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, the Company had adjourned its previously announced extraordinary general meeting of shareholders on December 30, 2024 (the “Meeting”) to 10:30 a.m. Eastern…
Sunset Market Commentary – Action Forex
Markets French yields remained at the center of attention. Since prime minister Bayrou called a budget-related confidence vote for September 8, OATs have underperformed not only vs. Bund & swap but even vs. Italian BTPs. That continued today, be it at a less alarming pace than on Monday. Some French tenors including the 5-year one…
XTB’s Kaczmarzyk: “Q4 2025 Launch Is Realistic” If KNF Approves Options
More Volume, More Revenue, Better Traders: Crypto Derivatives with Shift Markets More Volume, More Revenue, Better Traders: Crypto Derivatives with Shift Markets More Volume, More Revenue, Better Traders: Crypto Derivatives with Shift Markets More Volume, More Revenue, Better Traders: Crypto Derivatives with Shift Markets More Volume, More Revenue, Better Traders: Crypto Derivatives with Shift Markets…
USD higher. Yields higher. Stocks lower. | Forexlive
The USD is moving higher. Looking at the dollar index (DXY) the price is testing the 200 day MA at 103.79. The price moved above that level on Friday reaching a high of 103.88, before failing and rotating lower. The high has just extended to 103.803. Get and stay above to 200 day MA, and…
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) — Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, reaffirms his commitment to preserving equity for shareholders. Amid ongoing discussions about financing approaches in the biotech sector, Dr. Saadi emphasizes his distinct strategy, which prioritizes…
